“Miracle Cancer Drug” Gleevec Sales Threatened Following Novartis Rebate Scandal

SEOUL, April 10 (Korea Bizwire) – South Korea’s health authorities are considering a suspension of health insurance reimbursement for imatinib, a highly effective leukemia drug sold under the brand name of Gleevec (or Glivec), after its maker Novartis was found to have provided illegal kickbacks to doctors.  The Swiss multinational pharmaceutical company was investigated by prosecutors [...]